前沿论文｜CELL INTELLIGENCE

Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

PubMed 2026/01/08 发表Cancer Immunol ResQ1 · IF 7.9（JCR 2025）

Targeting the roots of myeloid malignancies with T cell receptors.

PubMed 2025/08/21 发表Nat Rev CancerQ1 · IF 60.7（JCR 2025）

CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment.

PubMed 2024/03/22 发表Mol Ther OncolQ1 · IF 8.5（JCR 2025）

前沿论文 3